XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Share-based Payment Arrangements (Tables)
 9 Months Ended
Sep. 30, 2023
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

 
  
Thirty-Nine Weeks Ended
 
  
Thirteen Weeks Ended
 
 
  
September 30,
2023
 
  
September 24,
2022
 
  
September 30,
2023
 
  
September 24,
2022
 
Total cost of the Plans during the period
    $ 4,270      $ 9,409      $  1,144      $ 3,599  
Amount of related income tax benefit recognized during the period
      (3,878 )       (5,219 )       (286 )       (949 ) 
    
 
 
     
 
 
     
 
 
     
 
 
  
Net cost of the Plans during the period
    $ 392      $ 4,190      $ 858      $  2,650  
    
 
 
     
 
 
     
 
 
     
 
 
  
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
 
  
Number of
RSUs
 
  
Weighted Average

Grant Date
Fair Value
 
Outstanding at December 31, 2022
      151,780      $ 115.80  
Granted
      41,460      $ 165.04  
Shares earned in excess of target
(1)
      79,176      $ 98.39  
Vested shares, including shares earned in excess of target
      (137,861 )     $ 97.97  
Forfeited
      (2,011 )     $  142.67  
    
 
 
           
Outstanding at September 30, 2023
      132,544      $ 138.94  
    
 
 
           
 
(1)
Represents additional shares earned under the February 1, 2019 and January 31, 2020 RSU awards as fiscal year 2022 financial results exceeded target performance level and under the April 24, 2018 and July 1, 2019 RSU awards as total shareholder return during the applicable performance period exceeded target performance level under each of those awards.
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
 
  
Number of Shares

and Deferred Stock
Units
 
  
Weighted Average

Grant Date

Fair Value
 
Non-vested
at December 31, 2022
      47,795      $ 138.30  
Granted
      22,714      $ 179.32  
Vested
      (24,161 )     $  138.35  
    
 
 
     
 
 
  
Non-vested
at September 30, 2023
      46,348      $ 158.38  
    
 
 
     
 
 
  
The fair value of each share of
non-vested
restricted stock issued and Deferred Stock Unit granted under the Plans is based on the fair value of a share of
the Company’s common stock on the date of grant. Shares of
non-vested
restricted stock are generally subject to vesting in three equal annual installments either on the first, second and third anniversary of the date of the grant or the third, fourth and fifth anniversary of the date of the grant, or 100% on the first, third or fifth anniversary of the date of the grant. For restricted stock awards granted under the 2022 DSCP, each recipient may elect to defer receipt of shares and instead receive restricted stock units (“Deferred Stock Units”), which represent contingent rights to receive shares of the Company’s common stock on the date of recipient separation
from service from the Board of Directors, or, if earlier, upon a change in control event of the Company. Deferred Stock Units become vested
100
% on the first anniversary of the date of the grant. Deferred Stock Units do not represent actual ownership in shares of the Company’s common stock and the recipient does not have voting rights or other incidents of ownership until the shares are issued. However, Deferred Stock Units do contain the right to receive dividend equivalent payments prior to settlement into shares.